Executive Director, Regulatory Affairs

🕒 Abril 17

Candidatar-se

Encontrar Vagas Remotas Similares

Receber Emails de Vagas Remotas

📊 Verifique sua pontuação de currículo para esta vaga

Melhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.

Enviar Currículo

Kyverna Therapeutics

SiteLinkedInTodas as Vagas

51 - 200 funcionários

Fundada em 2019

🧬 Biotecnologia

💊 Farmacêutico

🔬 Ciência

💰 $85.000.000 Series B em 2022-01

Biotechnology • Pharmaceuticals • Science

Kyverna Therapeutics é uma empresa biofarmacêutica centrada no paciente e em estágio clínico, focada no desenvolvimento de terapias celulares para pacientes que sofrem de doenças autoimunes. A empresa está na vanguarda das terapias com células CAR T, aproveitando o poder transformador das células T para potencialmente proporcionar remissão sustentada e sem tratamento para condições autoimunes. O principal candidato a terapia com células CAR T da Kyverna, o KYV-101, está avançando em ensaios clínicos visando várias doenças autoimunes, incluindo esclerose múltipla, miastenia grave, esclerose sistêmica e nefrite lúpica. Seu pipeline apresenta terapias inovadoras com receptores de antígenos quiméricos (CAR) T-cells em formatos autólogos e alogênicos voltados para doenças autoimunes mediadas por células B.

Descrição

• Provide strategic and operational regulatory leadership across Kyverna's cell therapy portfolio, with a focus on commercial readiness, labeling strategy, and health authority engagement. • Lead global regulatory strategy for Kyverna's development programs, aligning clinical, CMC, and commercial objectives from early development through post-approval lifecycle management. • Provide regulatory input to program governance, asset prioritization, and portfolio decisions, including scenario planning and risk mitigation. • Anticipate and address regulatory challenges related to cell therapy development, manufacturing, comparability, and long-term follow-up. • Serve as the primary senior regulatory interface with FDA, EMA, and other global health authorities. • Lead and/or support key regulatory meetings, including INTERACT, pre-IND, End-of-Phase, pre-BLA/MAA, Advisory Committees, and post-marketing commitments. • Drive regulatory negotiation strategy, including benefit-risk, endpoints, comparability, and post-approval requirements. • Own and drive labeling strategy from early development through approval, ensuring labels support commercial differentiation, patient access, and lifecycle value. • Lead development of Target Product Profiles (TPPs) and ensure alignment across Clinical, Regulatory, Commercial, and Market Access. • Partner with Commercial, Medical Affairs, and Market Access to ensure regulatory decisions support launch readiness, promotional strategy, and payer engagement. • Lead label negotiations with health authorities, balancing scientific evidence, regulatory expectations, and commercial objectives. • Oversee and contribute to the preparation, review, and submission of INDs, CTAs, BLAs/MAAs, briefing packages, orphan drug applications, and other regulatory filings. • Ensure submissions are high-quality, compliant, and strategically positioned. • Maintain oversight of submission timelines, dependencies, and risk management, providing clear communication to senior leadership. • Act as a strategic partner to Clinical Development, CMC, Research, Commercial, Legal, BD, and Alliance Management teams. • Provide regulatory due diligence and strategic input for business development, in-licensing, out-licensing, and partnership opportunities. • Oversee regulatory activities performed by CROs, consultants, and partners, ensuring quality and strategic alignment. • Lead, mentor, and scale a high-performing regulatory team, fostering accountability, development, and a culture of collaboration. • Establish and maintain regulatory policies, procedures, and infrastructure to support a growing, late-stage organization.

🎯 Requisitos

• Bachelor's degree in a scientific discipline required; advanced degree preferred. • 15+ years of progressive regulatory affairs experience in pharmaceutical or biotechnology, with significant advanced therapy experience. • Cell and/or gene therapy experience preferred; autoimmune disease experience highly preferred. • Demonstrated success leading global regulatory strategies through late-stage development and/or approvals, ideally including BLA/MAA experience. • Proven experience with labeling strategy development and negotiation, with strong understanding of commercialization impacts. • Deep knowledge of FDA regulations, ICH guidelines, and global regulatory frameworks; EMA and ex-US experience preferred. • Track record of effective engagement with FDA OTP and/or divisions overseeing autoimmune or immune-mediated diseases. • Strong executive communication skills with the ability to influence senior leadership and Board-facing audiences. • Demonstrated ability to lead and scale teams in a fast-paced, high-growth environment. Prior supervisory experience preferred. • Strategic mindset with the ability to balance scientific rigor, regulatory compliance, and commercial impact.

🏖️ Benefícios

• eligible for bonus • benefits • participation in the company's stock plan